• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECKMAN COULTER ACCESS TESTOSTERONE; RADIOIMMUNOASSAY, TESTOSTERONES AND DIHYDROTESTOSTERONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECKMAN COULTER ACCESS TESTOSTERONE; RADIOIMMUNOASSAY, TESTOSTERONES AND DIHYDROTESTOSTERONE Back to Search Results
Catalog Number 33560
Device Problem High Test Results (2457)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 06/20/2023
Event Type  Injury  
Manufacturer Narrative
A1: full patient identifier is (b)(6).A2, a4 and a5: the customer did not provide patient demographics such as age, date of birth, weight, ethnicity or race.H3 and h6: the access testosterone reagent was not returned for evaluation.No hardware errors, flags or other assay issues were reported in conjunction with this event.No other patient results were called into question.System performance indicators such as system check, calibration and quality control were passing within specifications at the time of the event.An aliquot of the patient sample was forwarded to the beckman coulter complaint handling unit (chu).Initial dilution testing performed by chu suggested presence of interferent; however, chu interference testing did not demonstrate presence of interferents in the sample.In conclusion, the cause of this event cannot be determined with the available information.
 
Event Description
On 20 july 2023 the customer reported obtaining erroneous repeatable elevated testosterone (access testosterone, part number 33560 and reagent lot number 338265) on their access (access 2 immunoassay analyzer, part number 81600n and serial number (b)(6)) for one patient beginning in (b)(6) 2023.The elevated testosterone results were released from the laboratory.There was a report of change to patient treatment or management in connection with this event.The customer reported the patient received an injection of firmagon on (b)(6) 2023 (dose administered not provided).There was no further report of change to patient treatment or management in connection with this event.Customer stated another sample was collected and sent to a reference lab (b)(6); lower results were obtained.Customer did not know reference lab testing methodology.Customer also reported sending a sample to another laboratory, (b)(6) laboratory and reported results of testing performed at (b)(6) laboratory matched the results obtained at quest.Customer reported the (b)(6) laboratory used a roche platform.No hardware errors or issues with other assays were reported in conjunction with this event.No other patient results were called into question.System performance indicators such as system check, calibration and quality control were passing within specifications at the time of the event.There were no issues reported with sample; sample type, volume collected, sample handling and processing information were not provided by the customer.The customer agreed to send sample to the beckman coulter complaint handling unit (chu) for interference testing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCESS TESTOSTERONE
Type of Device
RADIOIMMUNOASSAY, TESTOSTERONES AND DIHYDROTESTOSTERONE
Manufacturer (Section D)
BECKMAN COULTER
1000 lake hazeltine drive
chaska MN 55318
Manufacturer (Section G)
BECKMAN COULTER
1000 lake hazeltine drive
chaska MN 55318
Manufacturer Contact
angela vettel
250 s. kraemer blvd
brea, CA 92821
7149613625
MDR Report Key17509906
MDR Text Key321065602
Report Number2122870-2023-00087
Device Sequence Number1
Product Code CDZ
UDI-Device Identifier15099590231347
UDI-Public(01)15099590231347(17)240331(11)230401(10)338265
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 08/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/11/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/31/2024
Device Catalogue Number33560
Device Lot Number338265
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/01/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexMale
-
-